The Scientific Advisors team at Synapticure comprises a diverse group of experts who provide strategic guidance and scientific insight to advance ALS research and treatment initiatives. They collaborate with clinicians and biotech partners to develop innovative solutions that enhance patient care and inform clinical practices, ensuring that the company remains at the forefront of ALS care in the modern healthcare landscape.
Adam Schlifke
Scientific & Strategic Advisor
Ethan Perlstein
Scientific & Strategic Advisor
Jeff Rothstein
Scientific & Strategic Advisor
Jeremy Shefner
Scientific & Strategic Advisor
Lisa Suennen
Scientific & Strategic Advisor
Mark Koontz
Senior Associate Scientist
Nathan Bays
Scientific & Strategic Advisor
Sami Barmada
Scientific & Strategic Advisor
Sarah Coleman
Associate Scientist I
View all